Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001082466 | SCV000654689 | benign | Telangiectasia, hereditary hemorrhagic, type 5 | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000597100 | SCV000701629 | benign | not specified | 2016-10-11 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001082466 | SCV000885504 | benign | Telangiectasia, hereditary hemorrhagic, type 5 | 2023-11-29 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000757325 | SCV001822797 | likely benign | not provided | 2019-12-17 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002377164 | SCV002685592 | benign | Cardiovascular phenotype | 2022-05-05 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV001082466 | SCV002806282 | likely benign | Telangiectasia, hereditary hemorrhagic, type 5 | 2021-09-28 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000757325 | SCV005220663 | likely benign | not provided | criteria provided, single submitter | not provided |